CollPlant Biotechnologies Ltd
CLGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001631487
No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding CollPlant Biotechnologies Ltd changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 13 | 16 | +3 |
| Shares | 1.42M | 1.49M | +72.7K (+5.1%) |
| Value | $7.59M | $7.39M | −$198.4K (−2.6%) |
New holders (4)
Institutions that held CollPlant Biotechnologies Ltd at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AMH Equity Ltd | 75,647 | $376.0K | 0.56% |
| Redwood Wealth Management Group, LLC | 1,310 | $6.51K | 0.00% |
| Advisor Group Holdings, Inc. | 200 | $994 | 0.00% |
| Tower Research Capital LLC (TRC) | 1 | $5 | 0.00% |
Sold out (1)
Institutions that held CollPlant Biotechnologies Ltd at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Citadel Advisors LLC | 13,193 | $71.1K |